Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06585579 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)

Study acronym: ORIGYNE
StatusUnknown
PhaseNot applicable
SponsorBiocodex
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 5, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Biocodex
6 trials monitored
See all monitored trials
This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.
Trial Details
NCT Number NCT06585579
Lead Sponsor Biocodex
Conditions
(from sponsor)		 Cervicovaginitis
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov